CD38 and neoplasm: In addition to the complexity of CD38 expression on immune subpopulations, there are insufficient data to definitively indicate which function of CD38 would need to be targeted in order for effective tumor cell killing, or whether inhibition of both enzymatic and receptor functions would be necessary.